Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Trofile ESTA and short-term maraviroc response for HIV-1 coreceptor tropism prediction
2008-007208-28Phase 2Active
- Sponsor
- Asociación para el Estudio de las Enfermedades Infecciosas
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of maraviroc in Human immunodeficiency virus infection type 1, sponsored by Asociación para el Estudio de las Enfermedades Infecciosas. Primary endpoints: HIV coreceptor tropism, Correlation between Trofile ESTA and short-term virologic response to maraviroc and 1 more. Started Feb 2009; status: active.
02
Drugs
maraviroc
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2008-007208-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007208-28.